Location of Repository

Prevention of airway inflammation with topical cream containing imiquimod and small interfering RNA for natriuretic peptide receptor

By Xiaoqin Wang, Weidong Xu, Subhra Mohapatra, Xiaoyuan Kong, Xu Li, Richard F Lockey and Shyam S Mohapatra
Topics: Research
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:2291050
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles



    1. (2003). AM: Characterization of heme oxygenase 1 (heat shock protein 32) induction by atrial natriuretic peptide in human endothelial cells. Endocrinology
    2. (2006). An siRNA-based microbicide protects mice from lethal herpes simplex virus 2 infection. Nature
    3. (2006). Blume-Peytavi U: 40 nm, but not 750 or 1,500 nm, nanoparticles enter epidermal CD1a+ cells after transcutaneous application on human skin.
    4. (2006). De W: Treatment of allergic airway inflammation and hyperresponsiveness by imiquimod modulating transcription factors T-bet and GATA-3. Chin Med J (Engl)
    5. (2004). Effect of chitosan on epithelial cell tight junctions. Pharm Res
    6. (1994). Espevik T: Characterization of binding and TNF-alpha-inducing ability of chitosans on monocytes: the involvement of CD14. Vaccine
    7. (2000). Florence AT: Effects of some non-ionic surfactants on transepithelial permeability in Caco-2 cells.
    8. (2002). Fukuhara S: Roles of toll-like receptors in natural interferon-producing cells as sensors in immune surveillance. Hum Immunol
    9. (2000). Gene expression in an intact ex-vivo skin tissue model following percutaneous delivery of cationic liposome-plasmid DNA complexes.
    10. (1998). Glucocorticoids induce a Th2 response in vitro. Dev Immunol
    11. (2002). HG: Efficacy of a novel chitosan formulation on fecal fat excretion: a doubleblind, crossover, placebo-controlled study.
    12. (2001). Leong KW: Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency.
    13. (1999). Leong KW: Oral gene delivery with chitosan – DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat Med
    14. (2000). Lordan JL: Epithelial-mesenchymal interactions in the pathogenesis of asthma.
    15. (2004). Lu DR: Transfection of mEpo gene to intestinal epithelium in vivo mediated by oral delivery of chitosan-DNA nanoparticles.
    16. (2005). Mohapatra SS: Inhibition of respiratory syncytial virus infection with intranasal siRNA nanoparticles targeting the viral NS1 gene. Nat Med
    17. (2006). Mohapatra SS: Thiolated chitosan nanoparticles enhance anti-inflammatory effects of intranasally delivered theophylline. Respir Res
    18. (2004). Natriuretic peptides and genesis of asthma: an emerging paradigm? J Allergy Clin Immunol
    19. (2006). Preclinical safety assessment of a DNA vaccine using particle-mediated epidermal delivery in domestic pig, minipig and mouse. Exp Toxicol Pathol
    20. (2006). Ramratnam B: Engineering mucosal RNA interference in vivo. Mol Ther
    21. (2007). RF: Doxorubicin skin penetration from monoolein-containing propylene glycol formulations.
    22. (2000). Role of CD28/B7 costimulation in the dexamethasone-induced suppression of IFN-gamma.
    23. (2006). SK: Expression of growth differentiation factor 9 in the oocytes is essential for the development of primordial follicles in the hamster ovary. Endocrinology
    24. (2006). Skin targeted DNA vaccine delivery using electroporation in rabbits II.
    25. (2006). Sun PL: Imiquimod attenuates airway inflammation and decreases the expression of thymus and activation regulated chemokine in allergic asthmatic mice. Chin Med J (Engl)
    26. (2002). Topical delivery of plasmid DNA using biphasic lipid vesicles (Biphasix).

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.